Clinical Trial Update: Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of telmisartan (MICARDIS) in children and adolescents with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 2 | Status: COMPLETED